Zeposia Effective in Keeping Ulcerative Colitis in Remission, Phase 3 Study Shows
News, Ulcerative colitis
Zeposia (ozanimod), an investigational anti-inflammatory medicine, significantly increased clinical remission and mucosal healing in patients with ulcerative colitis (UC), a form of inflammatory bowel disease (IBD), Bristol Myers Squibb announced ... Read more